U.S. markets open in 3 hours 57 minutes

Guardant Health, Inc. (GH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
133.15-10.55 (-7.34%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close143.70
Bid0.00 x 900
Ask163.00 x 800
Day's Range130.08 - 144.80
52 Week Range55.90 - 181.07
Avg. Volume1,100,827
Market Cap13.372B
Beta (5Y Monthly)0.50
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Why Guardant Health Stock Sank Today
    Motley Fool

    Why Guardant Health Stock Sank Today

    What happened Shares of Guardant Health (NASDAQ: GH) were sinking 7.9% as of 3:05 p.m. EST on Thursday. The genomics company didn't report any news that would cause its stock to slide. Instead, Guardant Health's shares were pulled down by the broader market sell-off.

  • Like Guardant Health? You'll Love CareDx
    Motley Fool

    Like Guardant Health? You'll Love CareDx

    A picks-and-shovels precision medicine play that doesn't tend to grab headlines, CareDx (NASDAQ: CDNA) describes itself as "focused on better outcomes through personalized transplant surveillance." Its suite of offerings encompasses the spectrum of transplant medicine: waitlist management for patients, high-resolution donor matching, AI analysis for risk of transplant rejection, and diagnostic blood and urine testing for transplant failure and/or rejection. Investors intrigued by larger peers such as Guardant Health (NASDAQ: GH) may want to consider CareDx as a better healthcare bargain at a fraction of the price.

  • New Strong Sell Stocks for March 1st

    New Strong Sell Stocks for March 1st

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today